Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02254577 · ClinicalTrials.gov registry record · Phase 4
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
A Phase 4 study of Infertility, sponsored by Shady Grove Fertility Reproductive Science Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,139
- Enrollment target
- 14
- Study locations
NCT02254577 is a Phase 4 study of Infertility that has completed, run by Shady Grove Fertility Reproductive Science Center. The registered enrollment target is 1,139 participants, below the 7,574-participant average among 74 other Infertility trials with a reported enrollment target (85% lower). The trial reports 14 study locations across 4 states.
The verdict
NCT02254577, a Phase 4 study of Infertility, has completed, sponsored by Shady Grove Fertility Reproductive Science Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,139 participants
- Enrollment target
- 14
- Study locations
Study Summary
To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.
Conditions Studied
Interventions
- DRUG Endometrin® plus Progesterone in Oil (PIO)
- DRUG Progesterone in Oil (PIO) Only
Study Locations (14)
Maryland
- Shady Grove Fertility Center - Annapolis
- Shady Grove Fertility Center - Baltimore
- Shady Grove Fertility Center - Bel Air
- Shady Grove Fertility Center - Columbia
- Shady Grove Fertility Center - Frederick
- Shady Grove Fertility Center - Rockville
- Shady Grove Fertility Center - Towson
Virginia
- Shady Grove Fertility Center - Annandale
- Shady Grove Fertility Center - Leesburg
- Shady Grove Fertility Center - Woodbridge
District of Columbia
- Shady Grove Fertility Center - Washington D.C.
- Shady Grove Fertility Center - Washington D.C.
Pennsylvania
- Shady Grove Fertility - Camp Hill
- Shady Grove Fertility Center - Chesterbrook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-04-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02254577
The ClinicalTrials.gov registry entry for NCT02254577 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,139 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,574-participant average among 74 other Infertility trials with a reported enrollment target (85% lower). The listed sponsor is Shady Grove Fertility Reproductive Science Center, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Endometrin® plus Progesterone in Oil (PIO) is the first listed.
NCT02254577 reports 14 study locations spanning 4 distinct geographic areas - top geographies include Maryland, Virginia, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02254577 about?
NCT02254577 is a clinical study titled "Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer". To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.
What is the current status of trial NCT02254577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,139 participants. The study started on 2014-10. Estimated completion is 2018-04-27.
What conditions does trial NCT02254577 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT02254577?
The interventions under investigation include: Endometrin® plus Progesterone in Oil (PIO) (DRUG), Progesterone in Oil (PIO) Only (DRUG).
Who is sponsoring clinical trial NCT02254577?
This trial is sponsored by Shady Grove Fertility Reproductive Science Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02254577 being conducted?
This trial has 14 study locations across District of Columbia, Maryland, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
RECRUITING · Phase 4
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Menopur Mixed Protocol
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.